Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 2, 2018
Preclinical News

Carl June, NIBR teams document CAR T resistance

BioCentury | Aug 31, 2018
Clinical News

CAR Ts Kymriah, Yescarta get green light in EU

BioCentury | Aug 27, 2018
Company News

CAR Ts Kymriah, Yescarta get green light in EU

BioCentury | May 30, 2018
Preclinical News

Tet2 disruption improves Kymriah efficacy

Items per page:
1 - 10 of 71